Money Made Available For Meniere’s Disease Treatment Tests
This post was written by Mike on July 18, 2010
Posted Under: General Information on Meniere's Disease / Syndrome
Posted Under: General Information on Meniere's Disease / Syndrome
San Diego-based Otonomy, which is developing treatments for Meniere’s disease, said today that it has raised $10M in a Series A financing round. The round came from Avalon Ventures. According to Otonomy, the funding will go towards supporting the ongoing clinical trial for its compound, to initiate IND studies for a second compound, and early-stage development of a third program. Otonomy is headed by Jay Lichter, who is also a managing director at Avalon Ventures. Otonomy’s first product is a sustained release formulation of steroid dexamethasone.
Tags: Avalon, Beating Meniere's Disease, Clinical Trial, Dexamethasone, Jay Lichter, Managing Director, Meniere S Disease, meniere's, Meniere's and Nutritional Supplements, Meniere's Syndrome, menieres's disease tests, Money, Release Formulation, Relief from Meniere's symptoms, research, San Diego, Stage Development, Sustained Release
Reader Comments
Mike: thanks to your web side I went to HEI of Los Angeles, for the DNA test and also I registered for the clinical trial OTO-104.
I didn’t qualified for the trial since my condition is apparently bilateral and they trial is only done for unilateral. Do you have any source of info for bilateral Meniere’s? If you don’t know right now, keep me in mind in case in the future some study appears for bilateral.
Sorry Jorge, we hav eno info on trials for bilateral Meniere’s tests at the moment but yes we will keep it in mind and of cours, like any new Meniere’s disease info we come across we will post it on this blog.